Prelude Therapeutics Incorporated
PRLD · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$20 | -$31 | -$32 | -$29 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $4 | $4 | $4 |
| Change in WC | -$3 | $1 | -$7 | $4 |
| Other Non-Cash | $3 | $0 | $0 | -$1 |
| Operating Cash Flow | -$19 | -$26 | -$34 | -$21 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$0 | -$0 | -$0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | -$25 | -$9 | -$7 |
| Inv. Sales/Matur. | $40 | $36 | $72 | $29 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $40 | $12 | $62 | $22 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | -$0 | -$0 | -$0 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | -$0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$0 | -$0 | $0 | -$0 |
| Financing Cash Flow | -$0 | $0 | -$0 | -$0 |
| Forex Effect | $1 | $0 | $0 | $0 |
| Net Chg. in Cash | $22 | -$15 | $28 | $1 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $26 | $44 | $17 | $15 |
| End Cash | $48 | $30 | $44 | $17 |
| Free Cash Flow | -$19 | -$26 | -$34 | -$21 |